Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 12, 1998

View Archived Issues

Company Profile: Vivus

Dainippon in-licenses Wakunaga fluoroquinolone

Bio-Technology General establishes Eastern European licensing agreement for recombinant insulin

Endorex, Elan agree to form joint venture for vaccine development

Merck continues to devote extensive R&D efforts to FTase inhibitors

Japanese launch announced for HIV protease inhibitor

Good in vitro activity reported for Novartis PKC inhibitor

First clinical results reported for SC-68240

Cell adhesion inhibitors from Merck KGaA

Chiroscience synthesizes new MMP/TNF-inhibitory agents

Ketoacid ETA antagonists from Warner-Lambert

Novel thalidomide prodrugs reported in patent literature

Neurogen describes D3 receptor-specific ligands

Novel binding mechanism described for Shin Nippon's H+/K+-ATPase inhibitor

Phase I/II results reported for Searle's new hematopoietic growth factor

New mycotoxin with antitumor and favorable hematological effects

New hematopoietic growth factor family presented

Effects of neutrophil elastase inhibitor MDL-101146 in two arthritis models

More dopamine receptor ligands from Merck & Co.

Diatide's acute thrombosis imaging agent scheduled for review by FDA panel

New urinary incontinence product from Biomatrix cleared for clinical trials

New antiviral peptides from Boehringer Ingelheim

Arris completes acquisition of Sequana

FDA approves Photofrin for early-stage lung cancer

Two SBIR grants awarded to Cubist for antiinfective drug discovery

Anti-HIV fusion inhibitor from Trimeris advances to phase II

CDK inhibitor induces apoptosis and tumor necrosis in a dog with malignant melanoma

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...